AIM

AIM ImmunoTech Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

2.660
+0.620
+30.39%
Pre Market: 3.250 +0.59 +22.18% 06:15 03/31 EDT
OPEN
2.270
PREV CLOSE
2.040
HIGH
3.450
LOW
2.240
VOLUME
28.72M
TURNOVER
--
52 WEEK HIGH
14.81
52 WEEK LOW
0.3810
MARKET CAP
68.00M
P/E (TTM)
-0.4049
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AIM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AIM stock price target is 3.833 with a high estimate of 6.50 and a low estimate of 2.000.

EPS

AIM News

More
  • OMI, PSTV, GRPN and WMC among midday movers
  • Seeking Alpha - Article · 17h ago
  • Mid-Morning Market Update: Markets Open Higher; Cal-Maine Foods Profit Tops Expectations
  • Benzinga · 20h ago
  • ABT, DD among premarket gainers
  • Seeking Alpha - Article · 20h ago
  • NRZ, TLRY among premarket gainers
  • Seeking Alpha - Article · 4d ago

Industry

Biotechnology & Medical Research
+4.00%
Pharmaceuticals & Medical Research
+4.75%

Hot Stocks

Symbol
Price
%Change

About AIM

AIM ImmunoTech Inc., formerly Hemispherx Biopharma, Inc., is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.
More

Webull offers kinds of AIM ImmunoTech Inc stock information, including AMEX:AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions.